ERICA DUERBECK: Open Payments
NPI 1487340220 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 56 payments from 18 companies in 2025. Trend: 2023 $237 · 2024 $2,373 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $226 |
| ABIOMED | 3 | $191 |
| Boston Scientific Corporation | 11 | $166 |
| Stryker Corporation | 1 | $159 |
| Solventum Corporation | 1 | $153 |
| Amgen Inc. | 9 | $137 |
| E.R. Squibb & Sons, L.L.C. | 1 | $95 |
| BridgeBio Pharma, Inc. | 3 | $81 |
| Philips North America LLC | 3 | $72 |
| Merck Sharp & Dohme LLC | 3 | $51 |
Products named: LEQVIO, ARTIX MT, V.A.C.ULTA, Repatha, WATCHMAN FLX, CAMZYOS, Attruby, VERQUVO.
Industry payments across VA — which companies pay providers there.
